Reply to Ross' commentary: Reproductive benefit through newborn screening: Preferences, policy and ethics

European Journal of Human Genetics

Volumn 20, Issue 5, 2012, Pages 486-487

  Bombard, Yvonne ^a,b   Miller, Fiona A ^c  

^a YALE UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LETTER; MEDICAL ETHICS; NEWBORN SCREENING; PHENYLKETONURIA; PRIMARY HEALTH CARE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; SICKLE CELL TRAIT;

ANEMIA, SICKLE CELL; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; NEONATAL SCREENING;

EID: 84859890168     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.25     Document Type: Letter

References (20)

1. Bombard Y, Miller FA, Hayeems RZ et al: Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders. Eur J Hum Genet 2012; 20: 498-504.
2. Ross LF: Newborn screening for sickle cell disease: whose reproductive benefit? Eur J Hum Genet 2012; 20: 484-485.
3. Health Council of the Netherlands: Screening: Between Hope and Hype. Hague: Health Council of the Netherlands, 2008.
4. Bailey Jr DB, Skinner D, Warren SF: Newborn screening for developmental disabilities: reframing presumptive benefit. Am J Public Health 2005; 95: 1889-1893. (Pubitemid 41572356)
5. Bailey DBJ, Beskow LM, Davis AM, Skinner D: Changing perspectives on the benefits of newborn screening. Ment Retard Dev Disabil 2006; 12: 10.
6. Alexander D, van Dyck PC: A vision of the future of newborn screening. Pediatrics 2006; 117: 350-354.
7. Bombard Y, Miller FA, Hayeems RZ, Avard D, Knoppers BM: Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening. Eur J Hum Genet 2010; 18: 751-760.
8. National Screening Committee: Second Report of the UK National Screening Committee. London: Department of Health, Social Services and Public Safety, 2000.
9. Botkin JR, Clayton EW, Fost NC et al: Newborn screening technology: proceed with caution. Pediatrics 2006; 117: 1793-1799. (Pubitemid 46071411)
10. Wilson JMG, Jungner G: Principles and Practice of Screening for Disease. Geneva: World Health Organization, 1968.
11. Bombard Y, Miller FA, Hayeems RZ et al: The expansion of newborn screening: is reproductive benefit an appropriate pursuit? Nat Rev Genet 2009; 10: 666-667.
12. Creighton S, Almqvist EW, MacGregor D et al: Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet 2003; 63: 462-475. (Pubitemid 36944091)
13. Ropka ME, Wenzel J, Phillips EK, Siadaty M, Philbrick JT: Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev 2006; 15: 840-855. (Pubitemid 43823507)
14. Sanderson SC, O'Neill SC, Bastian LA, Bepler G, McBride CM: What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Public Health Genomics 2010; 13: 116-124.
15. Mischler EH, Wilfond BS, Fost N et al: Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling. Pediatrics 1998; 102: 44-52. (Pubitemid 28309244)
16. Ciske DJ, Haavisto A, Laxova A, Rock LZM, Farrell PM: Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics 2001; 107: 699-705. (Pubitemid 32268454)
17. Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi DW: Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center. Genet Med 2001; 3: 411-415.
18. Ross LF, Clayton EW: Clinical and ethical considerations in managing carrier detection. Am J Public Health 2009; 99: 1348-1349.
19. Miller FA, Hayeems RZ, Robert JS: Carrier detection and clinical uncertainty: the case for public health ethics. Am J Public Health 2009; 99: 1349-1350.
20. Miller FA, Paynter M, Hayeems RZ et al: Understanding sickle cell carrier status identified through newborn screening: a qualitative study. Eur J Hum Genet 2010; 18: 303-308.